Express Pharma
APRIL 8, 2025
A successful campaign drives engagement and shapes social norms through consistent digital communication – Bhavna Singh, Vice President Corporate Communications at Bharat Serums and Vaccines (BSV) “Communication is as effective as the content and the channels used. Digital Multi stakeholder communication rests heavily on engagement with the audience.
STAT
APRIL 9, 2025
A national public health organization is calling for Health Secretary Robert F. Kennedy Jr. to resign the federal post he assumed just weeks ago, citing “implicit and explicit bias and complete disregard for science.” Georges Benjamin, executive director of the American Public Health Association, said in a statement on Wednesday that concerns raised during Kennedy’s confirmation hearing last month have been realized, followed by massive reductions in staff at key health agen
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog: Biosimilars
APRIL 8, 2025
By Kurt R. Karst The FDA Reduction-in-Force (Termination)or RIF(T)announced last week has resulted in countless stories in the press and on personal LinkedIn accounts from those RIFd. As the dust begins to settle and we all assess what this means for the future of FDA and the public health, generally, this blogger wanted to call out one particular division in the Office of Generic Drugs (OGD), funded by user fees under the Generic Drug User Fee Amendments (GDUFA), that was eradicated and what t
PharmaVoice
APRIL 11, 2025
The tariff war has prompted new calls to reshore manufacturing. Several large pharmas have already made the leap.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Drug Channels
APRIL 9, 2025
It's time for Drug Channels annual update of vertical integration among insurers, PBMs, specialty pharmacies, and healthcare services within U.S. drug channels. As you can see below, we have revised, renovated, and refurbished our infamous illustration of the major vertical business relationships among the largest companies. Proponents of these vertical integration arrangements argue that they create opportunities to mine healthcare costs.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Drug Patent Watch
APRIL 9, 2025
"Unlocking New Hope for Neurological Disorders As we continue to push the boundaries of medical innovation, I'm excited to share with you a game-changing development in the fight against neurological disorders. At the forefront of this revolution is AI-based drug repurposing. By leveraging cutting-edge technology, researchers are re-examining existing medications to identify new uses for treating conditions such as Alzheimer's, Parkinson's, and multiple sclerosis.
European Pharmaceutical Review
APRIL 11, 2025
The National Institute For Health and Care Excellence ( NICE )s has recommended a new combination treatment for advanced breast cancer patients. AstraZenecas Truqap (capivasertib) in combination with fulvestrant is indicated as a treatment option for around 1,100 UK adults with hormone receptor (HR)-positive HER2-negative breast cancer with certain genetic mutations.
Express Pharma
APRIL 11, 2025
His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, Deputy Prime Minister, and Minister of Defence of the UAE, has inaugurated DP World’s Free Trade Warehousing Zone (FTWZ) the Nhava Sheva Business Park (NSBP) in Mumbai, India. The launch of the facility represents a step forward in reinforcing the economic and trade partnership between India and the UAE.
STAT
APRIL 8, 2025
Last week’s layoffs across the Department of Health and Human Services left a significant casualty in the vast ecosystem of government-backed science: an entire division focused on researching pain. The reduction in force enacted last week by Health Secretary Robert F. Kennedy Jr. eliminated all but one full-time position, out of roughly a dozen, within the National Institutes of Health Office of Pain Policy and Planning, a unit devoted to coordinating pain-related research across t
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaVoice
APRIL 7, 2025
So far, the science and safety seem solid. But is the world emotionally ready to shift the responsibility of contraception to men?
Pharmafile
APRIL 10, 2025
Dosium Touchdose has gone live at West Middlesex University Hospital, UK, a clinical decision support technology proven to significantly reduce prescribing errors. This follows go-live at both Chelsea and Westminster Hospital last month, and St Marys Hospital last summer, marking the final stage of rollout across the entire West London Childrens Healthcare (WLCH) partnership.
Express Pharma
APRIL 8, 2025
The Indian Society for Clinical Research (ISCR) has announced the appointment of Dr Seema Pai as President for the 20252028 term. Dr Pai succeeds Dr Sanish Davis, who served as President from 2021 to 2025. The new leadership team also includes Anirban Roychowdhury as Honorary General Secretary and Amita Bhave as Treasurer. Dr Pais appointment comes at a time when the clinical research sector in India is adapting to changes in technology and evolving regulatory structures.
STAT
APRIL 11, 2025
In an unexpected move, the U.S. Food and Drug Administration announced plans this week to reduce — and possibly replace — animal testing with other methods for developing certain medicines in a bid to lower R&D costs and, eventually, the prices for prescription drugs. The agency will encourage researchers to use computer modeling and artificial intelligence to predict how a drug will perform, as well as organs-on-a-chip, which are miniaturized devices that mimic organs and tiss
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharma Marketing Network
APRIL 7, 2025
How do pharma brands cut through the noise and bring the right audiences to their digital doorstep? As digital channels continue to expand, identifying and optimizing the best traffic drivers has become more critical than ever for pharma marketing teams. In this article, well unpack the most effective sources of website traffic in 2025from organic search to paid campaignsand explore how marketing leaders can turn clicks into meaningful engagement.
Drug Patent Watch
APRIL 9, 2025
Patient-Centric Approaches to Maintaining Brand Value As the pharmaceutical industry continues to evolve, one thing remains clear: patients are at the forefront of every decision. At DrugPatentWatch, we've seen firsthand how patient-centric approaches can make all the difference in maintaining brand value. In our latest blog post, we explore the importance of putting patients first in brand strategy.
Express Pharma
APRIL 8, 2025
To address growing demand from the pharmaceutical industry, Asahi Kasei has launched a new division, Asahi Kasei Life Science, effective from 1 April 2025. The new structure is designed to unify its bioprocess businesses and streamline services offered to pharmaceutical partners across drug development and manufacturing. Asahi Kasei Life Science now houses the companys bioprocess-related units, including Planova virus removal filters, Microfilters BioOptimal, and associated equipment used in the
STAT
APRIL 7, 2025
Health insurers in the private Medicare business have a big incentive to diagnose their members with lots of health conditions: The government pays them more money. A new study shows the extent to which the biggest player in that business, UnitedHealth Group , stands out from the rest for its prowess at raking in extra cash from that program. Medicare Advantage insurers pulled in an estimated $33 billion in additional payment from the government in 2021 as a result of these extra diagnoses
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmafile
APRIL 10, 2025
TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the progression of Alzheimer’s disease over a period of at least 18 months. If approved by regulators, HMTM could be the first oral treatment for the disease that targets the tau protein. Conventionally, targeted therapies for Alzheimers focused on amyloid protein […] The post Research finds tablet effective in slowing progression of Alzheimers disease over 18 months appeared f
Pharma Times
APRIL 10, 2025
The model could lead to more targeted treatments for the disease
Express Pharma
APRIL 9, 2025
Biocon Biologics (BBL), a subsidiary of Biocon (BSE code: 532523, NSE: BIOCON), has announced that the U.S. Food and Drug Administration (FDA) has approved JOBEVNE (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab), for intravenous use. JOBEVNE is a recombinant humanised monoclonal antibody used in the treatment of multiple types of cancer. JOBEVNE functions as a vascular endothelial growth factor (VEGF) inhibitor.
STAT
APRIL 9, 2025
“This year is going to be the year AI agents are going to get deployed,” NVIDIA CEO Jensen Huang declared at this year’s Consumer Electronics Show. But what are AI agents, and how do they apply to health care? Several health tech companies have jumped in on agents. One of the early entrants, Hippocratic AI, has a lineup of AI “nurses” that health systems can deploy for specific workflows, such as discussing cervical cancer screening or checking in on a chronic
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
European Pharmaceutical Review
APRIL 10, 2025
There is worldwide concern around the use of PFAS. In the EU, a joint PFAS Restriction Proposal under REACH was submitted, aiming for a full ban by 2028/2030. This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products.
Pharma Times
APRIL 10, 2025
Johnson & Johnsons Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration
Express Pharma
APRIL 8, 2025
Steris Healthcare, a pharmaceutical company headquartered in Mumbai with operations in Navi Mumbai, has unveiled a 50 crore growth strategy aimed at expanding its manufacturing capacity, entering new regional markets, and launching an Initial Public Offering (IPO) in FY 202627. The company, which recently crossed 100 crore in annual revenue, plans to strengthen its national presence through a multi-pronged approach.
STAT
APRIL 7, 2025
Robert F. Kennedy Jr. will likely delay his appearance before the Senate’s health committee by several weeks, even as he makes historic changes to the Department of Health and Human Services and contends with a surging measles outbreak. Senate health committee Chair Bill Cassidy (R-La.) and ranking member Bernie Sanders (I-Vt.) publicly asked the secretary to appear on April 10.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
PharmaVoice
APRIL 7, 2025
The FDA is much more flexible in approving first-in-class drugs compared to European regulators.
Pharmafile
APRIL 9, 2025
The cancer biotech company Infinitopes has gained approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to evaluate its ITOP1 vaccine targeting oesophageal cancer. This marks the first ever trial to administer a cancer vaccine in a neoadjuvant setting while the primary tumour remains. With Clinical Trial Application (CTA) approval, the upcoming phase […] The post Infinitopes launches first-in-human trial of vaccine targeting oesophageal cancer appeared first on Phar
Express Pharma
APRIL 9, 2025
The Federation of Pharma Entrepreneurs (FOPE), in collaboration with PharmaState Academy, conducted the 18th session of its ongoing PULSE (Pharma Upgradation & Learning Series for Excellence) initiative. The session focused on the manufacture of sterile drug products in line with the Revised Schedule M, bringing together key stakeholders and experts from across the pharmaceutical manufacturing ecosystem.
Expert insights. Personalized for you.
91 
Let's personalize your content